Editor’s Perspectives – February 2018

CombinaTexas 2018 February 10 – 11 , 2018

In this talk we give combinatorial proofs of q-Stirling identities using restricted growth words. This includes a poset theoretic proof of Carlitz’s identity, a new proof of the q-Frobenius identity of Garsia and Remmel and of Ehrenborg’s Hankel q-Stirling determinantal identity. We also develop a two parameter generalization to unify identities of Mercier and include a symmetric function versi...

In the literature: February 2018

Correspondence to Professor Andrés Cervantes; andres. cervantes@ uv. es Liquid biopsies may identify minimaL residuaL disease after reseCtion in Lung CanCer Non-invasive liquid biopsies may transform the management of patients with cancer. Circulating tumour DNA (ctDNA) derived from cancer cells can be identified in most patients with advanced cancer, representing a potential non-invasive sourc...

Burns Evidence Update February 2018 ( Quarterly )

Introduction: Severe burns result in prolonged hypermetabolism and skeletal muscle catabolism. Rehabilitative exercise training (RET) programs improved muscle mass and strength in severely burned children. The combination of RET with A-blockade or testosterone analogs showed improved exercise-induced benefits on body composition and muscle function. However, the effect of RET combined with mult...

Huntington’s Disease Clinical Trials Corner: February 2018

In the second edition of the Huntington’s Disease Clinical Trials Corner we list all currently registered and ongoing clinical trials, summarise the top-line results of the recently-announced IONIS-HTTRX trial (NCT02519036), expand on Wave Life Sciences’ PRECISION-HD1 (NCT03225833) and PRECISION-HD2 (NCT03225846), and cover one recently finished trial: the FIRST-HD deutetrabenazine trial (NCT01...

Cover vol. 15, no. 1, February 2018